<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Drug Research - Latest News &amp; Updates on Drug Research</title>
	<atom:link href="https://www.worldpharmatoday.com/drug-research/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Mon, 13 Jul 2026 07:44:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Drug Research - Latest News &amp; Updates on Drug Research</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Generative AI Advancing Novel Therapeutic Drug Discovery</title>
		<link>https://www.worldpharmatoday.com/drug-research/generative-ai-advancing-novel-therapeutic-drug-discovery/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 13 Jul 2026 07:44:04 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/generative-ai-advancing-novel-therapeutic-drug-discovery/</guid>

					<description><![CDATA[<p>The pharmaceutical sector is currently witnessing a profound shift in the methodology used to identify new chemical and biological entities. For decades, the discovery process relied heavily on high-throughput screening, where millions of existing molecules were tested against a specific biological target in the hope of finding a match. While this method yielded many successful [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/generative-ai-advancing-novel-therapeutic-drug-discovery/">Generative AI Advancing Novel Therapeutic Drug Discovery</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Machine Learning Improving Predictive Toxicology Testing</title>
		<link>https://www.worldpharmatoday.com/drug-research/machine-learning-improving-predictive-toxicology-testing/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 13 Jul 2026 07:33:58 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Featured]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/machine-learning-improving-predictive-toxicology-testing/</guid>

					<description><![CDATA[<p>The pharmaceutical industry is currently facing a critical challenge in the management of safety risks associated with new drug candidates. For decades, the high rate of attrition during late-stage clinical trials has been a primary driver of the rising costs of drug development. Often, molecules that showed promise in early research failed in humans due [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/machine-learning-improving-predictive-toxicology-testing/">Machine Learning Improving Predictive Toxicology Testing</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>AI Optimising Drug Development Costs and Timelines</title>
		<link>https://www.worldpharmatoday.com/drug-research/ai-optimising-drug-development-costs-and-timelines/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 13 Jul 2026 07:21:47 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/ai-optimising-drug-development-costs-and-timelines/</guid>

					<description><![CDATA[<p>The pharmaceutical industry is currently facing a period of intense structural adjustment as the costs associated with bringing a new therapy to market continue to rise. For decades, the industry has operated under a model where the average cost of developing a successful drug was estimated at approximately $2.6 billion, a figure that includes the [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/ai-optimising-drug-development-costs-and-timelines/">AI Optimising Drug Development Costs and Timelines</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>AI Revealing Drug Targets for Neurodegenerative Disorders</title>
		<link>https://www.worldpharmatoday.com/drug-research/ai-revealing-drug-targets-for-neurodegenerative-disorders/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 13 Jul 2026 06:56:52 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/ai-revealing-drug-targets-for-neurodegenerative-disorders/</guid>

					<description><![CDATA[<p>The pharmaceutical industry has long struggled with the immense complexity of conditions affecting the central nervous system. For decades, the high failure rate in clinical trials for Alzheimer&#8217;s and Parkinson&#8217;s disease has been a source of frustration for researchers and a significant financial burden for investors. The primary challenge lies in the intricate and often [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/ai-revealing-drug-targets-for-neurodegenerative-disorders/">AI Revealing Drug Targets for Neurodegenerative Disorders</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>AI Transforming Cancer Drug Discovery and Development</title>
		<link>https://www.worldpharmatoday.com/drug-research/ai-transforming-cancer-drug-discovery-and-development/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 13 Jul 2026 06:24:40 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/ai-transforming-cancer-drug-discovery-and-development/</guid>

					<description><![CDATA[<p>The global oncology sector is currently undergoing a significant shift as the complexity of the disease continues to outpace traditional research methods. For decades, the search for effective treatments was defined by a broad approach that often failed to account for the unique genetic profile of individual tumors. This reality resulted in high failure rates [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/ai-transforming-cancer-drug-discovery-and-development/">AI Transforming Cancer Drug Discovery and Development</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>AI Accelerating Rare Disease Drug Discovery Programs</title>
		<link>https://www.worldpharmatoday.com/drug-research/ai-accelerating-rare-disease-drug-discovery-programs/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 13 Jul 2026 06:16:38 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/ai-accelerating-rare-disease-drug-discovery-programs/</guid>

					<description><![CDATA[<p>The pharmaceutical sector is currently witnessing a fundamental shift in how orphan drugs are identified and moved through the clinical pipeline. For decades, the primary challenge for researchers has been the sheer scarcity of patient data and the immense biological complexity inherent in thousands of distinct rare conditions. Traditional methods of drug development often failed [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/ai-accelerating-rare-disease-drug-discovery-programs/">AI Accelerating Rare Disease Drug Discovery Programs</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>In Vivo CAR-T Engineering Sets a New Oncology Standard</title>
		<link>https://www.worldpharmatoday.com/drug-research/in-vivo-car-t-engineering-sets-a-new-oncology-standard/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 27 Jun 2026 07:52:49 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/in-vivo-car-t-engineering-sets-a-new-oncology-standard/</guid>

					<description><![CDATA[<p>The emergence of chimeric antigen receptor T cell therapy has been one of the most significant breakthroughs in the history of hematology oncology. By re engineering a patient’s own immune cells to recognize and attack cancer, researchers have achieved unprecedented remission rates in patients with advanced leukemias and lymphomas. However, the current generation of CAR-T [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/in-vivo-car-t-engineering-sets-a-new-oncology-standard/">In Vivo CAR-T Engineering Sets a New Oncology Standard</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Radioligand Therapy Advances in Precision Oncology</title>
		<link>https://www.worldpharmatoday.com/drug-research/radioligand-therapy-advances-in-precision-oncology/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 27 Jun 2026 07:52:33 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Drug Research]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/radioligand-therapy-advances-in-precision-oncology/</guid>

					<description><![CDATA[<p>The oncology sector is witnessing a fundamental change in the way systemic radiation is delivered to patients. Historically, radiotherapy was administered from an external source, which, while effective at killing tumor cells, often caused significant damage to the surrounding healthy tissue. This limitation necessitated a move toward more targeted approaches that could deliver therapeutic radiation [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/radioligand-therapy-advances-in-precision-oncology/">Radioligand Therapy Advances in Precision Oncology</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proximity Therapeutics Unlock New Druggable Frontiers</title>
		<link>https://www.worldpharmatoday.com/drug-research/proximity-therapeutics-unlock-new-druggable-frontiers/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 27 Jun 2026 07:52:09 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/proximity-therapeutics-unlock-new-druggable-frontiers/</guid>

					<description><![CDATA[<p>The pharmaceutical industry has historically focused on a narrow subset of the human proteome. For decades, the majority of small molecule drugs were designed to bind to the active sites of enzymes or receptors, effectively inhibiting their function. While this approach has been successful for many conditions, it is estimated that nearly eighty percent of [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/proximity-therapeutics-unlock-new-druggable-frontiers/">Proximity Therapeutics Unlock New Druggable Frontiers</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>AI Automation Is Accelerating Drug Discovery at Scale</title>
		<link>https://www.worldpharmatoday.com/drug-research/ai-automation-is-accelerating-drug-discovery-at-scale/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 27 Jun 2026 07:50:18 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/ai-automation-is-accelerating-drug-discovery-at-scale/</guid>

					<description><![CDATA[<p>The traditional pharmaceutical research and development model has long been characterized by high costs, long timelines, and a high rate of failure. For every drug that successfully reaches the market, thousands of candidates fall by the wayside during the discovery and preclinical phases. This inefficiency is a significant burden on the industry, limiting the number [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/ai-automation-is-accelerating-drug-discovery-at-scale/">AI Automation Is Accelerating Drug Discovery at Scale</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
